Veterinary Medicines

IZOVAC ND IB IBD REO

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Avian reovirus, strain S1133, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Download as PDF

Product identification

Medicine name:
IZOVAC ND IB IBD REO
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Ulster, Inactivated
  • Avian reovirus, strain S1133, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    64.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Newcastle disease virus, strain Ulster, Inactivated
    16.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian reovirus, strain S1133, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain Winterfield 2512, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA16
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Izo S.r.l.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Izo S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."